A novel de novo MYH9 mutation in MYH9-related disease: A case report and review of literature
- PMID: 31977897
- PMCID: PMC7004752
- DOI: 10.1097/MD.0000000000018887
A novel de novo MYH9 mutation in MYH9-related disease: A case report and review of literature
Abstract
Introduction: MYH9-related disease (MYH9-RD) is a rare autosomal dominant disorder caused by mutations in MYH9, which is responsible for encoding nonmuscle myosin heavy chains IIA (NMMHCIIA). MYH9-RD is clinically characterized by congenital macrothrombocytopenia, granulocyte inclusions variably associated with the risk of developing progressive sensorineural deafness, cataracts and nephropathy.
Patient concerns: A 5-year-old boy had a history of a mild bleeding tendency and chronic thrombocytopenia, first identified at four months of age. No other family members were noted to have similar clinical features or hematologic disorders.
Diagnoses: The boy was diagnosed with MYH9-RD. Light microscopic examination of peripheral blood films (Wright-Giemsa stain) showed marked platelet macrocytosis with giant platelets and basophilic Döhle-like inclusions in 83% of the neutrophils. Immunofluorescence analysis disclosed a type II pattern, manifested by neutrophils which contained several circle-to-oval shaped cytoplasmic NMMMHCA-positive granules. Sequencing analysis of MYH9-RD genes was carried out and revealed a novel missense mutation of c.97T>G (p.W33G) in the patient but not in his parents.
Intervention: No treatment is necessary. Recognition of MYH9-RD is important to Avoiding unnecessary and potentially harmful treatments.
Outcomes: The patient's condition remained stable during the follow-up.
Conclusions: As a result of identifying this missense mutation in this particular case, we have added c.97T>G (p.W33G) to the broad spectrum of potential MYH9 mutations.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures


Similar articles
-
Diagnosis and treatment of MYH9-RD in an Australasian cohort with thrombocytopenia.Platelets. 2018 Dec;29(8):793-800. doi: 10.1080/09537104.2017.1356920. Epub 2017 Nov 1. Platelets. 2018. PMID: 29090586
-
R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17.Clin Genet. 2015 Jul;88(1):85-9. doi: 10.1111/cge.12438. Epub 2014 Jul 26. Clin Genet. 2015. PMID: 24890873
-
Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease.Ear Hear. 2016 Jan-Feb;37(1):112-20. doi: 10.1097/AUD.0000000000000198. Ear Hear. 2016. PMID: 26226608
-
MYH9 Associated nephropathy.Nefrologia (Engl Ed). 2019 Mar-Apr;39(2):133-140. doi: 10.1016/j.nefro.2018.08.008. Epub 2018 Nov 22. Nefrologia (Engl Ed). 2019. PMID: 30471777 Review. English, Spanish.
-
[Renal diseases related to MYH9 disorders].G Ital Nefrol. 2017 Apr;34(2):40-57. G Ital Nefrol. 2017. PMID: 28682562 Review. Italian.
References
-
- Hannoun C, Dab W, Cohen JM. A new influenza surveillance system in France: the Ile-de-France “GROG”. 1. Principles and methodology. Eur J Epidemiol 1989;5:285–93. - PubMed
-
- Favier R, Feriel J, Favier M, et al. First successful use of eltrombopag before surgery in a child with MYH9-related thrombocytopenia. Pediatrics 2013;132:e793–5. - PubMed
-
- Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost 2009;35:189–203. - PubMed
-
- Eckly A, Strassel C, Freund M, et al. Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation. Blood 2009;113:3182–9. - PubMed
-
- Seri M, Pecci A, Di Bari F, et al. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 2003;82:203–15. - PubMed
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous